Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
Presentation on PPE and standard precautions
Предложенный вашему вниманию проект документа для дискуссии, озаглавленный "Отпринуждения к единству действий: преодоление наркозависимости путем лечения, а не н...аказания" был подготовлен с целью пропаганды похода, в основе которого лежит лечение людей, страдающих наркотической зависимостью. В настоящем докладе в общих чертах представлена модель, в рамках которой то или иное лицо из системы уголовного правосудия направлено на лечение в медицинское учреждение, которое более эффективно по сравнению с принудительным лечением и связано с менее жесткими ограничениями свободы, меньшей степенью стигматизации и более благоприятными перспективами как для индивида, так и для общества.
more
This study aimed to estimate the cost-effectiveness of a community-based rehabilitation (CBR) programme known as Inspire2Care (I2C), implemented in Nepal by Karuna Foundation Nepal. In the absence of any gold standard methodology to measure cost-effectiveness, the authors developed a new methodology... to estimate the programme’s achievements and cost-effectiveness.
more
Psychiatry de l'enfant et pediatrie
Chapitre I.1
Edition en français Traduction : Virginie Stalin
Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA
Quality of Life for Children with Cancer: Modules on Pediatric Palliative Care. Module 3: Quality of life in hospitalized children with cancer.
Antimicrobial resistance (AMR) – the ability of microorganisms to resist antimicrobial treatments, especially antibiotics – has a direct impact on human and animal health and carries a heavy economic burden due to higher costs of treatments and reduced productivity caused by sickness. AMR is res...ponsible for an estimated 33,000 deaths per year in the EU. It is also estimated that AMR costs the EU €1.5 billion per year in healthcare costs and productivity losses.
more
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
DHS Working Papers No. 90.
Also published in Spanish (2013) with the title: Informe sobre la epilepsia en América Latina y el Caribe - ISBN 978-92-75-31776-1